Regulation of Cox-2 by Cyclic AMP Response Element Binding Protein in Prostate Cancer: Potential Role for Nexrutine

We recently showed that NexrutineR, a Phellodendron amurense bark extract, suppresses proliferation of prostate cancer cell lines and tumor development in the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Our data also indicate that the antiproliferative effects of NexrutineR are mediat...

Full description

Bibliographic Details
Main Authors: Rita Ghosh, Gretchen E. Garcia, Katherine Crosby, Hiroyasu Inoue, Ian M. Thompson, Dean A. Troyer, Addanki P. Kumar
Format: Article
Language:English
Published: Elsevier 2007-11-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558607800170
_version_ 1828553022753472512
author Rita Ghosh
Gretchen E. Garcia
Katherine Crosby
Hiroyasu Inoue
Ian M. Thompson
Dean A. Troyer
Addanki P. Kumar
author_facet Rita Ghosh
Gretchen E. Garcia
Katherine Crosby
Hiroyasu Inoue
Ian M. Thompson
Dean A. Troyer
Addanki P. Kumar
author_sort Rita Ghosh
collection DOAJ
description We recently showed that NexrutineR, a Phellodendron amurense bark extract, suppresses proliferation of prostate cancer cell lines and tumor development in the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Our data also indicate that the antiproliferative effects of NexrutineR are mediated in part by Akt and Cyclic AMP response element binding protein (CREB). Cyclooxygenase (Cox-2), a pro-inflammatory mediator, is a CREB target that induces prostaglandin E2 (PGE2) and suppresses apoptosis. Treatment of LNCaP cells with NexrutineR reduced tumor necrosis factor α-induced enzymatic as well as promoter activities of Cox-2. NexrutineR also reduced the expression and promoter activity of Cox-2 in PC-3 cells that express high constitutive levels of Cox-2. Deletion analysis coupled with mutational analysis of the Cox-2 promoter identified CRE as being sufficient for mediating NexrutineR response. Immunohistochemical analysis of human prostate tumors show increased expression of CREB and DNA binding activity in high-grade tumors (three-fold higher in human prostate tumors compared to normal prostate; P = .01). We have identified CREB-mediated activation of Cox-2 as a potential signaling pathway in prostate cancer which can be blocked with a nontoxic, cost-effective dietary supplement like NexrutineR, demonstrating a prospective for development of NexrutineR for prostate cancer management.
first_indexed 2024-12-12T05:11:35Z
format Article
id doaj.art-3351bdc01e3f4eea8c21a21671ae8878
institution Directory Open Access Journal
issn 1476-5586
1522-8002
language English
last_indexed 2024-12-12T05:11:35Z
publishDate 2007-11-01
publisher Elsevier
record_format Article
series Neoplasia: An International Journal for Oncology Research
spelling doaj.art-3351bdc01e3f4eea8c21a21671ae88782022-12-22T00:36:53ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022007-11-0191189389910.1593/neo.07502Regulation of Cox-2 by Cyclic AMP Response Element Binding Protein in Prostate Cancer: Potential Role for NexrutineRita Ghosh0Gretchen E. Garcia1Katherine Crosby2Hiroyasu Inoue3Ian M. Thompson4Dean A. Troyer5Addanki P. Kumar6The Sandra and Stanley Rosenberg Family Laboratories, Department of Urology, University of Texas Health Science Center, San Antonio, TX 78229, USAThe Sandra and Stanley Rosenberg Family Laboratories, Department of Urology, University of Texas Health Science Center, San Antonio, TX 78229, USACell Signaling Technology, Inc., Danvers, MA, USADepartment of Food Science and Nutrition, Faculty of Human Life and Environment, Nara Women's University, Kita-Uoya-Nishimachi, Nara 630-8506, JapanThe Sandra and Stanley Rosenberg Family Laboratories, Department of Urology, University of Texas Health Science Center, San Antonio, TX 78229, USADepartment of Pathology, University of Texas Health Science Center, San Antonio, TX 78229, USAThe Sandra and Stanley Rosenberg Family Laboratories, Department of Urology, University of Texas Health Science Center, San Antonio, TX 78229, USAWe recently showed that NexrutineR, a Phellodendron amurense bark extract, suppresses proliferation of prostate cancer cell lines and tumor development in the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Our data also indicate that the antiproliferative effects of NexrutineR are mediated in part by Akt and Cyclic AMP response element binding protein (CREB). Cyclooxygenase (Cox-2), a pro-inflammatory mediator, is a CREB target that induces prostaglandin E2 (PGE2) and suppresses apoptosis. Treatment of LNCaP cells with NexrutineR reduced tumor necrosis factor α-induced enzymatic as well as promoter activities of Cox-2. NexrutineR also reduced the expression and promoter activity of Cox-2 in PC-3 cells that express high constitutive levels of Cox-2. Deletion analysis coupled with mutational analysis of the Cox-2 promoter identified CRE as being sufficient for mediating NexrutineR response. Immunohistochemical analysis of human prostate tumors show increased expression of CREB and DNA binding activity in high-grade tumors (three-fold higher in human prostate tumors compared to normal prostate; P = .01). We have identified CREB-mediated activation of Cox-2 as a potential signaling pathway in prostate cancer which can be blocked with a nontoxic, cost-effective dietary supplement like NexrutineR, demonstrating a prospective for development of NexrutineR for prostate cancer management.http://www.sciencedirect.com/science/article/pii/S1476558607800170Cox-2 promoter activityprostate cancerCREBinflammationPGE2
spellingShingle Rita Ghosh
Gretchen E. Garcia
Katherine Crosby
Hiroyasu Inoue
Ian M. Thompson
Dean A. Troyer
Addanki P. Kumar
Regulation of Cox-2 by Cyclic AMP Response Element Binding Protein in Prostate Cancer: Potential Role for Nexrutine
Neoplasia: An International Journal for Oncology Research
Cox-2 promoter activity
prostate cancer
CREB
inflammation
PGE2
title Regulation of Cox-2 by Cyclic AMP Response Element Binding Protein in Prostate Cancer: Potential Role for Nexrutine
title_full Regulation of Cox-2 by Cyclic AMP Response Element Binding Protein in Prostate Cancer: Potential Role for Nexrutine
title_fullStr Regulation of Cox-2 by Cyclic AMP Response Element Binding Protein in Prostate Cancer: Potential Role for Nexrutine
title_full_unstemmed Regulation of Cox-2 by Cyclic AMP Response Element Binding Protein in Prostate Cancer: Potential Role for Nexrutine
title_short Regulation of Cox-2 by Cyclic AMP Response Element Binding Protein in Prostate Cancer: Potential Role for Nexrutine
title_sort regulation of cox 2 by cyclic amp response element binding protein in prostate cancer potential role for nexrutine
topic Cox-2 promoter activity
prostate cancer
CREB
inflammation
PGE2
url http://www.sciencedirect.com/science/article/pii/S1476558607800170
work_keys_str_mv AT ritaghosh regulationofcox2bycyclicampresponseelementbindingproteininprostatecancerpotentialrolefornexrutine
AT gretchenegarcia regulationofcox2bycyclicampresponseelementbindingproteininprostatecancerpotentialrolefornexrutine
AT katherinecrosby regulationofcox2bycyclicampresponseelementbindingproteininprostatecancerpotentialrolefornexrutine
AT hiroyasuinoue regulationofcox2bycyclicampresponseelementbindingproteininprostatecancerpotentialrolefornexrutine
AT ianmthompson regulationofcox2bycyclicampresponseelementbindingproteininprostatecancerpotentialrolefornexrutine
AT deanatroyer regulationofcox2bycyclicampresponseelementbindingproteininprostatecancerpotentialrolefornexrutine
AT addankipkumar regulationofcox2bycyclicampresponseelementbindingproteininprostatecancerpotentialrolefornexrutine